Chronic Thromboembolic Pulmonary Hypertension Clinical Trials

100 clinical trials for Chronic Thromboembolic Pulmonary Hypertension across international registries, including 19 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Chronic Thromboembolic Disease Registry — RECRUITING
• Frailty, Physical Capacity and Lung Function in Postoperative Pulmonary Endarterectomy Patients — RECRUITING
• 129Xe MRI Cardiopulmonary — RECRUITING · PHASE2
• Cardiac Self-Efficacy in Patients With Chronic Thromboembolic Pulmonary Hypertension — RECRUITING
• Registry of Patients With chrOnic thromboemboLic Pulmonary hypErTension — RECRUITING
• Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism — RECRUITING
• Proteomic Pattern Associated With the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension — RECRUITING
• Pulmonary Hypertension Association Registry — RECRUITING
• Pulmonary Hypertension Biorepository and Registry — RECRUITING
• Switching of Sildenafil to Riociguat in CTEPH Patients — RECRUITING · PHASE4
• Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART) — RECRUITING · PHASE3
• the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension — RECRUITING
• Chinese PE Multimodality Imaging Artificial Intelligence Study — RECRUITING
• BPA vs. PEA in CTEPH — RECRUITING · NA
• Change-a Multi-center Chronic Thromboembolic Pulmonary Hypertension （CTEPH） Database in China — RECRUITING
• Safety and Efficacy of Balloon Pulmonary Angioplasty in China — RECRUITING
• Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension — RECRUITING
• DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL — RECRUITING
• AN OPEN-LABEL EXTENSION STUDY OF THE LONG-TERM SAFETY, TOLERABILITY AND EFFICACY OF AMBRISENTAN IN SUBJECTS WITH INOPERABLE CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH). — RECRUITING
• To assess safety and tolerability, clinical effects of riociguat. To provide access to riociguat for patients with in-operable chronic thromboembolic pulmonary hypertension (CTEPH), or recurrent or persisting pulmonary hypertension (PH) after surgical treatment who are not satisfactorily treated and cannot participate in any other CTEPH trial. — COMPLETED · PHASE3
• Continuous Remote Haemodynamic Monitoring With CardioMEMS™ Following Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension: — NOT_YET_RECRUITING
• Effect of vasopressin versus norepinephrine on post-operative mean pulmonary arterial pressure following pulmonary endarterectomy surgery, a randomized open label trial — NOT_YET_RECRUITING · PHASE3
• What is the Role of the Exposome in Pulmonary Hypertension — NOT_YET_RECRUITING
• Prehabilitation for Patients Undergoing Elective Cardiac Surgery — COMPLETED · NA
• Vasopressor Agents in Pulmonary Hypertension Crisis — NOT_YET_RECRUITING · NA
• Effects of Riociguat on RIght VEntricular Size and Function in PAH and CTEPH — TERMINATED · PHASE4
• Computerized Decision Support to Increase Detection of Chronic Thromboembolic Pulmonary Hypertension in Patients With Prior Pulmonary Embolism — COMPLETED · NA
• Non-Invasive Measurement of Cardiac Output and Stroke Volume in PAH/CTEPH — WITHDRAWN · NA
• Dapagliflozin in Pulmonary Arterial Hypertension — COMPLETED · PHASE2
• Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy in Pulmonary Vascular Disease (PVD) — COMPLETED · NA
• Validation of SEARCH, a Novel Hierarchical Algorithm to Define Long-term Outcomes After Pulmonary Embolism — COMPLETED
• STOP-RIO: A randomized controlled non-inferiority trial to test the safety of discontinuation of riociguat after balloon pulmonary angioplasty in Chronic Thrombo-embolic Pulmonary Hypertension — TERMINATED · PHASE3
• Inspiratory Muscle Training in Pulmonary Hypertension — COMPLETED · NA
• A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension — TERMINATED · PHASE3
• TrEatment Approach in the Multimodal Era Registry — ACTIVE_NOT_RECRUITING
• A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies. — COMPLETED · PHASE3
• Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension — COMPLETED · PHASE2
• Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension — COMPLETED · PHASE2
• Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension — COMPLETED · PHASE3
• A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment — TERMINATED · PHASE3
• Right Atrial Fibrosis in Pulmonary Hypertension — COMPLETED
• Prevalence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism : (Preva-CTEPH) — COMPLETED · NA
• Balloon Pulmonary Angioplasty vs. Combined Approach With Pulmonary Artery Denervation in CTEPH: Effectiveness Comparison — OTHER · PHASE2
• RV Conductance Catheter Assessment During Balloon Pulmonary Angioplasty — OTHER
• High Altitude (HA) Residents With Pulmonary Vascular Diseseases (PVD), Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) vs Sea Level (LA) — OTHER · NA
• HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT) — OTHER · NA
• HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level) — OTHER · NA
• High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT) — OTHER · NA
• Impact of Pulmonary Endarterectomy on Sleep-Related Breathing Disorders in CTEPH: The IPES Trial — OTHER
• Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vit K Antagonists for Acute DVT and PE — COMPLETED · NA

Refine this search